🇺🇸 FDA
Pipeline program

PEMETREXED , KEYTRUDA 25 mg/mL concentrate for solution for infusion., CARBOPLATIN

APHP241011

Phase 3 small_molecule active

Quick answer

PEMETREXED , KEYTRUDA 25 mg/mL concentrate for solution for infusion., CARBOPLATIN for Adult patients with stage IV non squamous non-small cell lung cancer (NSCLC) is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
Adult patients with stage IV non squamous non-small cell lung cancer (NSCLC)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials